Michael Leuchten

Stock Analyst

(n/a)

# 4,651

Out of 4,653 analysts

9

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

Stocks Rated by Michael Leuchten

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVO Novo Nordisk	Downgrades: Sell	n/a	$105.32	-	4	Jun 28, 2022
	AZN AstraZeneca	Upgrades: Buy	n/a	$65.04	-	4	Feb 25, 2021
	SNY Sanofi	Downgrades: Underweight	n/a	$47.82	-	1	Jan 23, 2018

Novo Nordisk

Jun 28, 2022

Downgrades: Sell

Price Target: n/a

Current: $105.32

Upside: -

AstraZeneca

Feb 25, 2021

Upgrades: Buy

Price Target: n/a

Current: $65.04

Upside: -

Sanofi

Jan 23, 2018

Downgrades: Underweight

Price Target: n/a

Current: $47.82

Upside: -